SMAIO H1 2026 net loss widens to €1.2 million; operating loss widens to €1.7 million

SMAIO posted first-half 2026 net income - Group share loss of EUR 1.2 million; operating income loss widened to EUR 1.7 million. First-half 2026 sales rose 3% to EUR 5.1 million; operating expenses climbed 15% to EUR 5.9 million. Gross margin rate fell 4 percentage points to 81% in first-half 2026. Third-quarter 2026 sales were EUR 2 million, unchanged; first nine months sales rose 2% to EUR 7.2 million. Chairman and CEO Philippe Roussouly cited a shift in the U.S. surgeon base and highlighted a DePuy Synthes open-platform agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMAIO SA published the original content used to generate this news brief via (Ref. ID: 20261013903306) on October 13, 2026, and is solely responsible for the information contained therein. (C)